160 related articles for article (PubMed ID: 24652221)
1. Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes.
Dessì M; Di Giovamberardino G; Pieri M; Noce A; Zenobi R; Di Daniele N; Pastore A
Clin Exp Nephrol; 2015 Feb; 19(1):140-5. PubMed ID: 24652221
[TBL] [Abstract][Full Text] [Related]
2. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
3. Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.
Pastore A; De Angelis S; Casciani S; Ruggia R; Di Giovamberardino G; Noce A; Splendiani G; Cortese C; Federici G; Dessi' M
Clin Chem; 2006 Jan; 52(1):145-8. PubMed ID: 16391331
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
5. [Hyperhomocysteinemia and alternate vitamin supplementation].
De Angelis S; Noce A; Dessì M; Pastore A; Scaccia F; Trombetta M; Tozzo C; Splendiani G
G Ital Nefrol; 2007; 24(1):51-5. PubMed ID: 17342693
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
9. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China.
Ni J; Zhang L; Zhou T; Xu WJ; Xue JL; Cao N; Wang X
J Chin Med Assoc; 2017 Mar; 80(3):147-153. PubMed ID: 28094233
[TBL] [Abstract][Full Text] [Related]
10. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
[TBL] [Abstract][Full Text] [Related]
11. Physiologic changes in homocysteine metabolism in pregnancy: a longitudinal study in Spain.
Ubeda N; Reyes L; González-Medina A; Alonso-Aperte E; Varela-Moreiras G
Nutrition; 2011 Sep; 27(9):925-30. PubMed ID: 21367581
[TBL] [Abstract][Full Text] [Related]
12. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma.
Li J; Xu F; Zeng R; Gong H; Lan Y
J Glaucoma; 2016 Feb; 25(2):e94-8. PubMed ID: 26171850
[TBL] [Abstract][Full Text] [Related]
13. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Russo GT; Giandalia A; Romeo EL; Scarcella C; Gambadoro N; Zingale R; Forte F; Perdichizzi G; Alibrandi A; Cucinotta D
J Endocrinol Invest; 2016 Mar; 39(3):305-14. PubMed ID: 26233336
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
16. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
18. Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.
Födinger M; Veitl M; Skoupy S; Wojcik J; Röhrer C; Hagen W; Puttinger H; Hauser AC; Vychytil A; Sunder-Plassmann G
Kidney Int; 2003 Sep; 64(3):1095-100. PubMed ID: 12911562
[TBL] [Abstract][Full Text] [Related]
19.
Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
[TBL] [Abstract][Full Text] [Related]
20. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
